KRIBIOLISA™ Liraglutide (Victoza) ELISA

GLP-1 receptor agonist medicines, also called incretin mimetics, are a type of incretin-based medicine for type 2 diabetes that control pancreatic function. These medicines (Exenatide, Semaglutide, Lixisenatide, and Liraglutide) copy, or mimic, the action of GLP-1 made by your body.

Krishgen’s range of ELISA for GLP-1 agonists can be used for pharmacokinetic studies, including dosage regimen and therapy development.

About the Liraglutide assay:

• Uses highly specific antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity
• Recovery rates are 80 - 120%
• Validated as per US FDA guidelines for Bioassays
• Optimized for matrix effects to ensure higher sensitivity
• Uses the innovator drug as calibrator, and is optimized for biosimilars studies